{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:13:38Z","timestamp":1790327618956,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00535-019-01633-2","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T20:04:12Z","timestamp":1570737852000},"page":"227-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients"],"prefix":"10.1007","volume":"55","author":[{"given":"Kenichiro","family":"Enooku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeya","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Sasako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Okushin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nakagomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohjiro","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yotsuyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"1633_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1633_CR2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2017.12.006","volume":"68","author":"S Caldwell","year":"2018","unstructured":"Caldwell S, Marchesini G. Cryptogenic vs. NASH-cirrhosis: the rose exists well before its name. J Hepatol. 2018;68:391\u20132.","journal-title":"J Hepatol"},{"key":"1633_CR3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1665-2681(19)31748-X","volume":"8","author":"SH Caldwell","year":"2009","unstructured":"Caldwell SH, Lee VD, Kleiner DE, et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol. 2009;8:346\u201352.","journal-title":"Ann Hepatol"},{"key":"1633_CR4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1046\/j.1440-1746.2002.02881.x","volume":"17","author":"BP Mulhall","year":"2002","unstructured":"Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol. 2002;17:1136\u201343.","journal-title":"J Gastroenterol Hepatol"},{"key":"1633_CR5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig. 2005;115:1343\u201351.","journal-title":"J Clin Investig"},{"key":"1633_CR6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1464-5491.2007.02186.x","volume":"24","author":"JP Wilding","year":"2007","unstructured":"Wilding JP. The importance of free fatty acids in the development of type 2 diabetes. Diabet Med. 2007;24:934\u201345.","journal-title":"Diabet Med"},{"key":"1633_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/ijms17040479","volume":"17","author":"R Gambino","year":"2016","unstructured":"Gambino R, Bugianesi E, Rosso C, et al. Different serum free fatty acid profiles in NAFLD subjects and healthy controls after oral fat load. Int J Mol Sci. 2016;17:479.","journal-title":"Int J Mol Sci"},{"key":"1633_CR8","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/srep05832","volume":"4","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhao Y, Xu C, et al. Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci Rep. 2014;4:5832.","journal-title":"Sci Rep"},{"key":"1633_CR9","doi-asserted-by":"crossref","first-page":"G194","DOI":"10.1152\/ajpgi.00413.2005","volume":"290","author":"MW Bradbury","year":"2006","unstructured":"Bradbury MW. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G194\u201398.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1633_CR10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679\u201389.","journal-title":"Hepatology"},{"key":"1633_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.abb.2014.01.025","volume":"546","author":"H Schneider","year":"2014","unstructured":"Schneider H, Staudacher S, Poppelreuther M, et al. Protein mediated fatty acid uptake: synergy between CD36\/FAT-facilitated transport and acyl-CoA synthetase-driven metabolism. Arch Biochem Biophys. 2014;546:8\u201318.","journal-title":"Arch Biochem Biophys"},{"key":"1633_CR12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","volume":"29","author":"F Diraison","year":"2003","unstructured":"Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 2003;29:478\u201385.","journal-title":"Diabetes Metab"},{"key":"1633_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ajcn\/77.1.43","volume":"77","author":"JM Schwarz","year":"2003","unstructured":"Schwarz JM, Linfoot P, Dare D, et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003;77:43\u201350.","journal-title":"Am J Clin Nutr"},{"key":"1633_CR14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1478-3231.2009.02076.x","volume":"29","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Sepp\u00e4l\u00e4-Lindroos A, Vehkavaara S, et al. Liver fat and lipid oxidation in humans. Liver Int. 2009;29:1439\u201346.","journal-title":"Liver Int"},{"key":"1633_CR15","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1572-0241.2003.07725.x","volume":"98","author":"L Miele","year":"2003","unstructured":"Miele L, Grieco A, Armuzzi A, et al. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol. 2003;98:2335\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1633_CR16","first-page":"663","volume":"22","author":"M Nakamuta","year":"2008","unstructured":"Nakamuta M, Kohjima M, Higuchi N, et al. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Int J Mol Med. 2008;22:663\u20137.","journal-title":"Int J Mol Med"},{"key":"1633_CR17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","volume":"23","author":"S Dasarathy","year":"2011","unstructured":"Dasarathy S, Yang Y, McCullough AJ, et al. Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol. 2011;23:382\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1633_CR18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413\u20139.","journal-title":"Gastroenterology"},{"key":"1633_CR19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1633_CR20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00535-015-1148-y","volume":"51","author":"K Okushin","year":"2016","unstructured":"Okushin K, Tsutsumi T, Enooku K, et al. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease. J Gastroenterol. 2016;51:808\u201318.","journal-title":"J Gastroenterol"},{"key":"1633_CR21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","volume":"347","author":"I Issemann","year":"1990","unstructured":"Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645\u201350.","journal-title":"Nature"},{"key":"1633_CR22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","volume":"65","author":"R Kwok","year":"2016","unstructured":"Kwok R, Choi KC, Wong GL, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut. 2016;65:1359\u201368.","journal-title":"Gut"},{"key":"1633_CR23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1478-3231.2012.02781.x","volume":"32","author":"RP Myers","year":"2012","unstructured":"Myers RP, Pollett A, Kirsch R, et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 2012;32:902\u201310.","journal-title":"Liver Int"},{"key":"1633_CR24","doi-asserted-by":"crossref","first-page":"e0157358","DOI":"10.1371\/journal.pone.0157358","volume":"11","author":"HW Lee","year":"2016","unstructured":"Lee HW, Park SY, Kim SU, et al. Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease. PLoS One. 2016;11:e0157358.","journal-title":"PLoS One"},{"key":"1633_CR25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u201330.","journal-title":"J Hepatol"},{"key":"1633_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2008-1040554","volume":"8","author":"K Jungermann","year":"1988","unstructured":"Jungermann K. Metabolic zonation of liver parenchyma. Semin Liver Dis. 1988;8:329\u201341.","journal-title":"Semin Liver Dis"},{"key":"1633_CR27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00535-018-1472-0","volume":"53","author":"K Enooku","year":"2018","unstructured":"Enooku K, Kondo M, Fujiwara N, et al. Hepatic IRS1 and \u03b2-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients. J Gastroenterol. 2018;53:1261\u201375.","journal-title":"J Gastroenterol"},{"key":"1633_CR28","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/liv.12769","volume":"35","author":"VT M\u00e4nnist\u00f6","year":"2015","unstructured":"M\u00e4nnist\u00f6 VT, Simonen M, Hyysalo J, et al. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. Liver Int. 2015;35:1853\u201361.","journal-title":"Liver Int"},{"key":"1633_CR29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/db16-1167","volume":"66","author":"A Gastaldelli","year":"2017","unstructured":"Gastaldelli A, Gaggini M, DeFronzo RA. Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio metabolism study. Diabetes. 2017;66:815\u201322.","journal-title":"Diabetes"},{"key":"1633_CR30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-2275(20)39899-0","volume":"36","author":"GV Richieri","year":"1995","unstructured":"Richieri GV, Kleinfeld AM. Unbound free fatty acid levels in human serum. J Lipid Res. 1995;36:229\u201340.","journal-title":"J Lipid Res"},{"key":"1633_CR31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1043-2760(01)00427-1","volume":"12","author":"A Stahl","year":"2001","unstructured":"Stahl A, Gimeno RE, Tartaglia LA, et al. Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol Metab. 2001;12:266\u201373.","journal-title":"Trends Endocrinol Metab"},{"key":"1633_CR32","doi-asserted-by":"crossref","first-page":"19034","DOI":"10.1074\/jbc.M115.640292","volume":"290","author":"P Steneberg","year":"2015","unstructured":"Steneberg P, Sykaras AG, Backlund F, et al. Hyperinsulinemia enhances hepatic expression of the fatty acid transporter Cd36 and provokes hepatosteatosis and hepatic insulin resistance. J Biol Chem. 2015;290:19034\u201343.","journal-title":"J Biol Chem"},{"key":"1633_CR33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","volume":"134","author":"J Zhou","year":"2008","unstructured":"Zhou J, Febbraio M, Wada T, et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology. 2008;134:556\u201367.","journal-title":"Gastroenterology"},{"key":"1633_CR34","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/MCB.00138-16","volume":"36","author":"WG Garbacz","year":"2016","unstructured":"Garbacz WG, Lu P, Miller TM, et al. Hepatic overexpression of CD36 improves glycogen homeostasis and attenuates high-fat diet-induced hepatic steatosis and insulin resistance. Mol Cell Biol. 2016;36:2715\u201327.","journal-title":"Mol Cell Biol"},{"key":"1633_CR35","doi-asserted-by":"crossref","first-page":"21429","DOI":"10.1074\/jbc.M300287200","volume":"278","author":"GG Martin","year":"2003","unstructured":"Martin GG, Danneberg H, Kumar LS, et al. Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene. J Biol Chem. 2003;278:21429\u201338.","journal-title":"J Biol Chem"},{"key":"1633_CR36","doi-asserted-by":"crossref","first-page":"22186","DOI":"10.1074\/jbc.M803510200","volume":"283","author":"H Doege","year":"2008","unstructured":"Doege H, Grimm D, Falcon A, et al. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J Biol Chem. 2008;283:22186\u201392.","journal-title":"J Biol Chem"},{"key":"1633_CR37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.metabol.2010.10.003","volume":"60","author":"L Zhu","year":"2011","unstructured":"Zhu L, Baker SS, Liu W, et al. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. Metabolism. 2011;60:1001\u201311.","journal-title":"Metabolism"},{"key":"1633_CR38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/modpathol.2017.13","volume":"30","author":"JH Tsai","year":"2017","unstructured":"Tsai JH, Ferrell LD, Tan V, et al. Aggressive non-alcoholic steatohepatitis following rapid weight loss and\/or malnutrition. Mod Pathol. 2017;30:834\u201342.","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"1633_CR39","first-page":"S44","volume":"40","author":"EA Shaffer","year":"2006","unstructured":"Shaffer EA. Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. J Clin Gastroenterol. 2006;40(Suppl 1):S44\u2013S50.","journal-title":"J Clin Gastroenterol"},{"key":"1633_CR40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.sla.0000179652.07502.3f","volume":"242","author":"SG Mattar","year":"2005","unstructured":"Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242:610\u20137 (discussion 8\u201320).","journal-title":"Ann Surg"},{"key":"1633_CR41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0261-5614(92)90028-O","volume":"11","author":"MJ M\u00fcller","year":"1992","unstructured":"M\u00fcller MJ, Rieger A, Willmann O, et al. Metabolic responses to lipid infusions in patients with liver cirrhosis. Clin Nutr. 1992;11:193\u2013206.","journal-title":"Clin Nutr"},{"key":"1633_CR42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ajcn\/69.2.331","volume":"69","author":"RA Richardson","year":"1999","unstructured":"Richardson RA, Davidson HI, Hinds A, et al. Influence of the metabolic sequelae of liver cirrhosis on nutritional intake. Am J Clin Nutr. 1999;69:331\u20137.","journal-title":"Am J Clin Nutr"},{"key":"1633_CR43","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1073\/pnas.95.11.5987","volume":"95","author":"JD Horton","year":"1998","unstructured":"Horton JD, Bashmakov Y, Shimomura I, et al. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA. 1998;95:5987\u201392.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01633-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-019-01633-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01633-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T10:53:35Z","timestamp":1664621615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-019-01633-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1633"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01633-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"21 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}